From the Centre for Imaging Sciences (W.J.Z., G.J.M.P., J.H.N.) and Biomedical Imaging Institute (W.J.Z., G.J.M.P., J.H.N.), the University of Manchester, Oxford Rd, Manchester M13 9PT, England; North West Lung Research Centre, University Hospital of South Manchester, Manchester, England (R.M.N.); Personalised Healthcare and Biomarkers, AstraZeneca R&D, Macclesfield, England (S.S.Y., Y.Z.L.); and Bioxydyn Limited, Manchester, England (G.J.M.P.).
Radiology. 2016 Mar;278(3):906-16. doi: 10.1148/radiol.2015141876. Epub 2015 Oct 20.
To evaluate the contrast agent kinetics of dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging in healthy lungs and asthmatic lungs by using non-model-based semiquantitative parameters and to explore the relationships with pulmonary function testing and eosinophil level.
The study was approved by the National Research Ethical Committee (reference no. 11/NW/0387), and written informed consent was obtained from all individuals. Ten healthy subjects and 30 patients with asthma underwent pulmonary function tests, blood and sputum eosinophil counts, and 1.5-T DCE MR imaging within 7 days. Semiquantitative parameters of contrast agent kinetics were calculated from the relative signal intensity-time course curves on a pixel-by-pixel basis and were summarized by using whole-lung median values. The distribution heterogeneity was assessed by using the regional coefficient of variation. DCE MR imaging readouts were compared between groups by using one-way analysis of variance, and the relationships with pulmonary function testing and eosinophil counts were assessed by using Pearson correlation analysis.
Asthmatic patients showed significantly lower peak enhancement (P < .001) and initial areas under the relative signal intensity curve in the first 60 seconds (P = .002) and significantly reduced late-phase washout slope (P = .002) when compared with healthy control subjects. The distribution heterogeneity of bolus arrival time (P = .029), time to peak (P = .008), upslope of the first-pass peak (P = .011), and late-phase washout slope (P = .032), estimated by using the median coefficient of variation, were significantly higher in asthmatic patients than in healthy control subjects. These imaging readouts also showed significant linear correlations with measurements of pulmonary function testing but not with eosinophil level in patients with asthma.
The contrast agent kinetic characteristics of T1-weighted DCE MR images of asthmatic lungs are different from those of healthy lungs and are related to measurements of pulmonary function testing but not to eosinophil level.
利用非模型依赖的半定量参数评估健康肺和哮喘肺动态对比增强(DCE)磁共振成像(MRI)的对比剂动力学,并探讨与肺功能测试和嗜酸性粒细胞水平的关系。
本研究经国家伦理委员会批准(编号 11/NW/0387),所有参与者均签署书面知情同意书。10 名健康受试者和 30 名哮喘患者在 7 天内进行了肺功能测试、血液和痰中嗜酸性粒细胞计数以及 1.5T DCE MRI。在逐像素的基础上,从相对信号强度时间曲线计算对比剂动力学的半定量参数,并通过全肺中位数进行总结。采用区域变异系数评估分布异质性。采用单因素方差分析比较组间 DCE MRI 读数,采用 Pearson 相关分析评估与肺功能测试和嗜酸性粒细胞计数的关系。
与健康对照组相比,哮喘患者的峰值增强(P <.001)和前 60 秒相对信号强度曲线的初始面积(P =.002)明显降低,晚期洗脱斜率明显减小(P =.002)。哮喘患者的对比剂到达时间(P =.029)、达峰时间(P =.008)、第一通过峰值的上升斜率(P =.011)和晚期洗脱斜率(P =.032)的分布异质性中位数变异系数明显高于健康对照组。这些影像学指标与肺功能测试的测量值呈显著线性相关,但与哮喘患者的嗜酸性粒细胞水平无关。
哮喘肺 T1 加权 DCE MRI 的对比剂动力学特征与健康肺不同,与肺功能测试的测量值有关,与嗜酸性粒细胞水平无关。